Results 231 to 240 of about 1,934,259 (247)

Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study

Lancet, The, 2017
Helen K Reddel, Paul M O'byrne, William Busse   +2 more
exaly  

Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial

Lancet Oncology, The, 2012
Gerhard Ehninger, Christian Thiede, Martin Bornhäuser   +2 more
exaly  

Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials

Lancet Respiratory Medicine,the, 2018
Mona Bafadhel, Stephen I Rennard
exaly  

Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)

Lancet Respiratory Medicine,the, 2018
Xiaofei Wang, David Jones, David R Jones
exaly  

Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial

Lancet Diabetes and Endocrinology,the, 2016
Edward W Gregg, Jeanne M Clark, Mace Coday   +2 more
exaly  

Audience response technology: under‐appreciated value of post hoc analysis

Medical Education, 2011
Paul, Schick, Sandra, Abramson, James, Burke   +2 more
openaire   +2 more sources

Overview of Friedman’s test and post-hoc analysis

2012
D. G. Pereira, Afonso, Anabela
openaire   +1 more source

The Effect of Provider Case Volume on Cancer Mortality: Systematic Review and Meta-Analysis

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial

Lancet, The, 2016
Maria Sessa, Francesca Fumagalli, Cristina Baldoli   +2 more
exaly  

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144

Lancet Infectious Diseases, The, 2012
Merlin L Robb, Jaranit Kaewkungwal, Peter B Gilbert   +2 more
exaly